Orthocell Secures Approval for Remplir™ Use in U.S. Department of Defence and VA Hospitals
Orthocell has received approval to use its Remplir™ nerve repair device across U.S. Department of Defence and Veterans Affairs hospital networks, covering 51 military hospitals and 170 VA medical centers. The company plans to leverage its existing U.S. distributor network, which spans 17 states, to expand market access. This approval is expected to boost Orthocell's commercialization and revenue momentum in the U.S.
Topics: distribution network medical devices product expansion regenerative medicine US military healthcare